These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39188784)

  • 41. Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data.
    Okuno T; Macwan SA; Miller D; Norman GJ; Reaven P; Zhou JJ
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38768417
    [No Abstract]   [Full Text] [Related]  

  • 42. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Lin R; Brown F; James S; Jones J; Ekinci E
    Diabet Med; 2021 May; 38(5):e14528. PubMed ID: 33496979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefits of the addition of continuous or flash glucose monitoring versus standard practice using self-monitored blood glucose and haemoglobin A1c in the primary care of diabetes mellitus: a systematic review protocol.
    Kieu A; Govender RD; Östlundh L; King J
    BMJ Open; 2021 Aug; 11(8):e050027. PubMed ID: 34446495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis.
    Park C; Le QA
    Diabetes Technol Ther; 2018 Sep; 20(9):613-621. PubMed ID: 30095980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can flash glucose monitoring improve glucose management for Aboriginal and Torres Strait Islander peoples with type 2 diabetes? A protocol for a randomised controlled trial.
    Hachem M; Hearn T; Kelly R; Eer A; Moore B; Sommerville C; Atkinson-Briggs S; Twigg S; Freund M; O'Neal D; Story D; Brown A; McLean A; Sinha A; Furler J; O'Brien R; Tran-Duy A; Clarke P; Braat S; Koye DN; Eades S; Burchill L; Ekinci E
    Trials; 2024 Jul; 25(1):493. PubMed ID: 39030640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-life utilization of real-time continuous glucose monitoring: the complete picture.
    Ramchandani N; Arya S; Ten S; Bhandari S
    J Diabetes Sci Technol; 2011 Jul; 5(4):860-70. PubMed ID: 21880227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Home telemonitoring for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(24):1-38. PubMed ID: 23074529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
    Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
    Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
    [No Abstract]   [Full Text] [Related]  

  • 52. Real-World Use of Continuous Glucose Monitoring Systems Among Adolescents and Young Adults With Type 1 Diabetes: Reduced Burden, but Little Interest in Data Analysis.
    Huhn F; Lange K; Jördening M; Ernst G
    J Diabetes Sci Technol; 2023 Jul; 17(4):943-950. PubMed ID: 35255729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: A systematic review and meta-analysis.
    Kumar S; Soldatos G; Ranasinha S; Teede H; Pallin M
    J Cyst Fibros; 2023 Jan; 22(1):39-49. PubMed ID: 35906171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid.
    Frank J; Son D; Szafranski K; Poon Y
    J Manag Care Spec Pharm; 2024 Sep; 30(9):917-928. PubMed ID: 39109990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
    Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
    Ajjan RA
    Diabetes Technol Ther; 2017 May; 19(S2):S27-S36. PubMed ID: 28541132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.
    Herrero P; Alalitei A; Reddy M; Georgiou P; Oliver N
    Diabetes Technol Ther; 2021 Apr; 23(4):314-319. PubMed ID: 33064025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.